Source: Annual Congress 2002 - Pulmonary surfactant in the pathogenesis and treatment of acute respiratory failure
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
J. J. Haitsma, S. Uhlig, D. L. Poelma, B. Lachmann (Rotterdam, The Netherlands; Borstel, Germany). Translocation of TNF-α from the gut to the lung by VILI is reduced by exogenous surfactant therapy. Eur Respir J 2002; 20: Suppl. 38, 2335

Member's Comments

No comment yet.

Related content which might interest you: Translocation of TNF-α from the gut to the lung by VILI Source: Eur Respir J 2001; 18: Suppl. 33, 317s Year: 2001 Surfactant pretreatment preserves lung function in ischemia-reperfusion-injury of the lung Source: Eur Respir J 2005; 26: Suppl. 49, 221s Year: 2005 Lung function is improved by surfactant pre-treatment in ischemia-reperfusion-injury of the lung Source: Eur Respir J 2004; 24: Suppl. 48, 204s Year: 2004 Inhaled activated protein C protects mice from ventilator-induced lung injury Source: Annual Congress 2009 - Acute lung injury: biological mechanisms Year: 2009 The association between LASSBio596 and surfactant improves lung morpho-function and reduces the inflammatory process in experimental sepsis-induced acute lung injury Source: Annual Congress 2010 - Acute respiratory failure Year: 2010 Inhaled cationic salts modulate macrophage function to reduce inflammation during LPS induced lung injury Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Therapeutic lavage with rSP-C surfactant restores oxygenation and improves histological outcome in a rat lung lavage model of acute lung injury Source: Eur Respir J 2001; 18: Suppl. 33, 7s Year: 2001 Surfactant release into the alveolar space protects the lung from ventilation-induced injury Source: Annual Congress 2012 - The many roads to lung injury Year: 2012 Changes in pulmonary surfactant composition during bleomycin-induced lung injury Source: Eur Respir J 2006; 28: Suppl. 50, 397s Year: 2006 Surfactant therapy for acute lung injury and other lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 210s Year: 2003 Increased enzymatic hydrolysis of surfactant and its correction by glucocorticoids in acute lung injury Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Transgenic mice expressing a surfactant protein-B-urokinase-fusion protein in the distal respiratory epithelium show an attenuated fibrotic response to bleomycin-induced lung injury Source: Annual Congress 2005 - In vivo - approaches to lung injury Year: 2005 Mechanisms responsible for surfactant changes in sepsis-induced lung injury Source: Eur Respir J 2005; 26: 1074-1079 Year: 2005 Dexamethasone inhibits surfactant degradation during bleomycin-induced lung injury in rats Source: Eur Respir J 2006; 28: Suppl. 50, 855s Year: 2006 The influence of intratracheal surfactant-BL administration or [DCquote]empty“ phosphatidylcholine liposomes on lung surfactant level and alveolar macrophage activity in intact rat lungs Source: Eur Respir J 2003; 22: Suppl. 45, 73s Year: 2003 Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Dexamethasone reduces lung inflammation induced by alveolar stretch in mice Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 RAGE deficiency improves alveolar fluid clearance in LPS-induced acute lung injury by preventing downregulation of Na-K-ATPase and ENaC Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017 Pulmonary surfactant as drug delivery system to target lung epithelium: new approach for the treatment of epithelial injury after bleomycin challenge Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018